Abstract
Transduction with chimeric T-cell receptor genes can be used to redirect primary T lymphocytes to recognize specific antigens (Ags), including ovarian and breast cancer Ags. To extend this approach to colon cancer we report here redirection of T cells using a chimeric receptor recognizing the colon cancer-associated Ag EGP40. Chimeric T cell receptors were constructed by ligating single-chain genes of either of two EGP40-specific monoclonal antibodies (CO17.1A, GA733) to the Fc receptor γ-signaling chain. Retroviral vectors incorporating these constructs were used to transduce a murine T-cell line and human peripheral blood lymphocytes. These modified T cells were analyzed for specific recognition of colon cancer lines by measuring cytokine release and lytic activity against tumor targets. Murine lymphocytes transduced with the chimeric receptor based on GA733, but not CO17.1A, released cytokine specifically in response to EGP40-expressing colon cancer cell lines. Recognition of colon cancer targets by murine lymphocytes was blocked by the addition of GA733 antibody or soluble EGP40 Ag, confirming that colon cancer recognition is based on specific chimeric receptor-Ag interaction. Human lymphocytes transduced with chimeric GA733 specifically recognized colon carcinoma cells in cytokine release assays and lysed EGP40-expressing tumor cells. Genetic modification of T cells can be used to redirect T cells against EGP40-expressing tumor cells. The expression of chimeric GA733 in the autologous lymphocytes of patients may provide a source of tumor-reactive cells with therapeutic application against colon cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Daly, T., Royal, R., Kershaw, M. et al. Recognition of human colon cancer by T cells transduced with a chimeric receptor gene. Cancer Gene Ther 7, 284–291 (2000). https://doi.org/10.1038/sj.cgt.7700121
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700121
Keywords
This article is cited by
-
Strategies to genetically engineer T cells for cancer immunotherapy
Cancer Immunology, Immunotherapy (2016)
-
Chimeric Antigen Receptors for Cancer: Progress and Challenges
Current Stem Cell Reports (2015)
-
Chimerism of multiple monoclonal antibodies expressed in a single plant
Horticulture, Environment, and Biotechnology (2012)
-
T cell avidity and tumor recognition: implications and therapeutic strategies
Journal of Translational Medicine (2005)
-
Supernatural T cells: genetic modification of T cells for cancer therapy
Nature Reviews Immunology (2005)